A CCR2/CCR5 Antagonist Attenuates an Increase in Angiotensin II-Induced CD11b+ Monocytes from Atherogenic ApoE−/− Mice

Author： Major Terry   Olszewski Bronia   Rosebury-Smith Wendy  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.23, Iss.2, 2009-04, pp. : 113-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A dual CCR2/CCR5 chemokine antagonist, BMS-813160?

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. : 1919-1924

Informa Healthcare

Access to resources Recommend Favorite

Treatment of HIV infection with the CCR5 antagonist maraviroc

By Kromdijk Wiete   Huitema Alwin DR   Mulder Jan Willem  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1215-1223

Informa Healthcare

Access to resources Recommend Favorite

CCR1 and CCR2 Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1539-1552

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1504-1514

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of SC-52458, a New Nonpeptide Angiotensin II Receptor Antagonist, on Increase in Cytoplasmic Ca 2+ Concentrations and Contraction Induced by Angiotensin II and K + -Depolarization in Guinea-Pig Taenia Coli

By Usune S.   Furukawa T.  

General Pharmacology, Vol. 27, Iss. 7, 1996-10 ,pp. : 1179-1185

Elsevier

Access to resources Recommend Favorite